My watch list
my.bionity.com  
Login  

Charles River to Acquire MPI Research

15-Feb-2018

Charles River announced that it has entered into a definitive agreement to acquire MPI Research for approximately $800 million in cash, subject to customary closing adjustments.

MPI is a premier non-clinical contract research organization (CRO) providing comprehensive testing services to biopharmaceutical and medical device companies worldwide. Acquiring MPI will enhance Charles River’s position as a leading global early-stage CRO by strengthening its ability to partner with clients across the drug discovery and development continuum.

James C. Foster, Chairman and Chief Executive Officer of Charles River Laboratories, commented, “In addition to meeting our disciplined acquisition criteria, MPI is an exceptional strategic fit for Charles River because it incorporates the key attributes we require in an acquisition: access to growing end markets, high-quality services, scientific expertise, and complementary capabilities. MPI’s one-million-square-foot, single-site facility in Michigan will provide needed capacity to meet current and future demand.”

Facts, background information, dossiers
  • Charles River
  • contract research o…
  • acquisitions
More about Charles River
  • News

    Charles River Laboratories acquires Agilux Laboratories, Inc.

    Charles River Laboratories International, Inc. announced that it has acquired Agilux Laboratories, Inc., a Worcester, Massachusetts-based contract research organization (CRO), that provides a suite of integrated discovery small and large molecule bioanalytical services, drug metabolism and ... more

    Charles River Laboratories acquires Blue Stream Laboratories

    Charles River Laboratories Acquires Blue Stream Laboratories Charles River Laboratories International announced that it has acquired Blue Stream Laboratories, Inc. Combining Blue Stream with Charles River’s existing discovery, safety assessment, and biologics capabilities creates a leading ... more

    Charles River Laboratories Acquires Oncotest GmbH

    Charles River Laboratories International, Inc. announced today that it has acquired Oncotest GmbH, a Freiburg, Germany-based contract research organization (CRO) providing discovery services for oncology, one of the largest therapeutic areas for biopharmaceutical research and development sp ... more

  • Events
    Webinar
    On-Demand

    Identifying Hits Using Virtual Screening

    Virtual screening (VS) is an established computational approach that employs knowledge to select potentially bioactive compounds for screening. Both structure-based and ligand-based VS is typically applied to large virtual chemical collections to shortlist compounds that have a better chanc ... more

    Webinar
    On-Demand

    Endotoxin Testing Limits, Method Development and Validation for Plasma-Derived Products

    Endotoxin testing continues to be an evolving field. Recently, concerns have arisen that endotoxin might not be detected with the LAL assay in many biologics. As part of the continuing conversation around this issue, the webinar discusses: Composition of plasma and endotoxin limits ... more

    Webinar
    On-Demand

    LER: A Biopharmaceutical Operational Reality Perspective

    The true impact of LER has yet to be elucidated. As such, the LER phenomenon continues to be investigated across many industries, including biopharmaceutical operations. We focus here on LER from an operational reality perspective: the growth of organisms in LER matrices and consequently th ... more

  • Companies

    Charles River Endotoxin Microbial Detection Europe SAS

    Charles River is the world's leading supplier of endotoxin detection products. As a global provider of rapid microbiological product solutions, our goal is to provide superior product quality and consistency to the scientific community. more

    Charles River Laboratories Clinical Services GmbH

    From our headquarters near Boston, MA, Charles River Laboratories' 7,500 employees serve clients as global providers of solutions that advance the drug discovery and development process. Our leading-edge products and services enable our clients to bring drugs to market faster and more eff ... more

    Charles River Laboratories, Inc.

    From our headquarters near Boston, MA, Charles River Laboratories' 7,500 employees serve clients as global providers of solutions that advance the drug discovery and development process. Our leading-edge products and services enable our clients to bring drugs to market faster and more eff ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE